Монголын Анагаахын Сэтгүүлүүдийн Холбоо (МАСХ)
Mongolian Journal of Health Sciences, 2007, 1(4)
Evaluation of cost- effectiveness of chemotherapy for stomach cancer patients
( Судалгааны өгүүлэл )

Uranchimeg O.', Erdenetsetseg G.2, DungerdorjD.2

'National Cancer Center, Mongolia

'School of Pharmacy, Health Sciences University of Mongolia

 
Абстракт

The aims of the study were to evaluate of cost effectiveness of chemotherapy for stomach cancer patients. Retrospective methods were conducted in the collection of the data.

Patients clinical data with the resources consumed were collected during a period of 5 years in 2000-2004 were treated from the National Cancer Center of Mongolia.

A total 400 patients chemotherapy patients were studied (225 single agent and 175 combination chemo­therapy patients).

Pharmacoeconomic analysis showed that drug expenses required for single chemotherapy is 236130±156734 MNT, drug expense required for combination A chemotherapy is 996253.4 ± 43518 MNT, and for Combination B chemotherapy is 1782901.3±42267 MNT.

Compared with combination A and B chemotherapy modality associated with lower cost and better cost per case alive ration, hence Combination A chemotherapy is the most cost effective therapy.

Ном зүй

1. Bootman J., Ghan W., Principles of Pharmacoeconomics. New York., 2001, pp. 21-25
2. Naranjio CA., Busto EM., A method for estimating the probability of Adverse Drug Reactions. Clinical Pharmacology Therapy. 198l.v.30(2),pp. 239-245
3. Uranchimeg O., Dungerdorj D., Erdenetsetseg G, An adherence audit of ADRs on patients after chemotherapy treatment, Oncology. UB. 2003. Number 1.
pp. 33-34
4. UranchimegO., ErdenetsetsegG, Dungerdorj D., et al, A study on assessment of Adverse Drug Reactions during the Stomach cancer chemotherapy,
Mongolian Journal of Health Sciences. UB. 2006, (136) 2. pp. 18-20
5. UranchimegO, Dungerdorj D, Erdenetsetseg., et al.Comparative study on cost effectiveness of chemotherapy for stomach cancer patients International
Conference on \"Essential Medicine -Sharing experiences: Accessibility, use, Quality, and Safety\" Ulaanbaatar, Mongolia. 21 - 23, Aug, 2006. p.50
6. Uranchimeg O, Dungerdorj D, Erdenetsetseg G, Ariunaa Kh, Saranchuluun M.,The study of Adverse Drug Reactions on Chemotherapy in National Cancer
Centre of Mongolia, For Clinical Oncology Pharmacy Symposium 17lh Pharmaceutical Society of Singapore 2005. p.50
7. UranchimegO, Dungerdorj D, Erdenetsetseg., et al, Evaluation of cost effective of chemotherapy for Stomach cancer population among Mongolia, For
Patient- Centred Practice Innovation- Centred Research ; 18lh Singapore Pharmacy Congress, 30. June - 3 July 2006. AB/008/68 p.43
8. UranchimegO, Dungerdorj D, Erdenetsetseg., A Study of Assessment side effects during the Stomach cancer chemotherapy. The lsl Asia-Pacific Oncology
Pharmacy Congress\" Bangkok, Tailand. 3-5 Aug. 2006. pp.83 - 85
 


Зохиогчийн оруулсан түлхүүр үгс


Нийтлэлийн нээгдсэн тоо: 401
Судлаачдын бусад өгүүлэл
Зохиогчийн эрх хуулиар хамгаалагдсан. Дэлхийн Эрүүл Мэндийн Байгууллага, ©  2012.
Вебийг бүтээсэн Слайд ХХК